Links

Homepage

Stock List

Search by Ticker

News

Login

Hologic (NASDAQ:HOLX)
Stock Analysis

HOLX80.7
▲ 0.25%0.2

Stock Analysis

The following stock analysis is based on 10.7 years of data (i.e. since Aug 03, 2012). All the stock history has been downloaded.

Stock Exchange

Hologic trades on the NasdaqGS exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Hologic

It is currently trading at $80.7 ($80.5 the previous day).

Financials

The next reporting date is in 25 days (2023 04 26).

CNN estimates profits for the upcoming quarter will be $0.88 per share ($959.2M). The current Canada / US exchange rate is 1.3511.



Over the past 12 months, $0 worth of shares have been purchased and $19807897 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 16.0% per year assuming steady exponential growth. The actual 5 year average is 13.02. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year73.7952698529413.5- Below Average
2 year71.3110601265829.4- Below Average
3 year65.20207100591737+ Above Average
4 year47.57893048128314.8+ Above Average
5 year41.4295038167940.4- Below Average
Hologic is projected by analysts to get to $89.00 within the next 12 months (10.3%), but preticted targets range from as high as $95.00 (17.7%) and as low as $75(-7.1%).

Risk

The worst drop it has had in recent years is -45.9%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.

Stock shape test

DAYS AG0PRICE
1077.68RISING
3082.73DROPPING
6079.66RISING
15062.51RISING
36574.68DROPPING
80078.93DROPPING
120052.305RISING
160040.47RISING
200037.02RISING


With an average increase of 16.0% year over year, if Hologic is bought at the worst time, Stockmarketizer analysts estimate it will take 34.4 months before the stock will recover to the original purchase price. The P/E value is 20.53. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Tradingview BuySell Widget

Yahoo News Feed

Abbott's (ABT) Epic Max Tissue Valve Receives FDA Approval

Fri, 31 Mar 2023 16:48:04 Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.... Read Full Article

3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio

Fri, 31 Mar 2023 15:58:03 Investors remain optimistic about DaVita (DVA) due to the strength in its DaVita Kidney Care.... Read Full Article

Catalent (CTLT) New Launch to Aid TPD Programs, Clinical Trials

Thu, 30 Mar 2023 16:34:04 Catalent's (CTLT) latest launch will likely aid in advancing the rational selection of orally developable TPD candidates and their progress into clinical trials.... Read Full Article

QIAGEN (QGEN) QIAxcel Connect Gets Red Dot Design Award

Thu, 30 Mar 2023 15:03:03 QIAGEN (QGEN) QIAxcel Connect automates the analysis of the size and quality of isolated DNA and RNA.... Read Full Article

Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?

Thu, 30 Mar 2023 13:40:01 Here is how Biohaven Ltd. (BHVN) and Hologic (HOLX) have performed compared to their sector so far this year.... Read Full Article

Here's Why Investors Should Retain Omnicell (OMCL) Stock Now

Wed, 29 Mar 2023 16:17:04 Investors are optimistic about Omnicell (OMCL) owing to its planned geographic expansion.... Read Full Article

Illumina (ILMN) to Enable Tertiary Analysis With New Launch

Wed, 29 Mar 2023 16:08:04 Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.... Read Full Article

Surmodics (SRDX) Gets FDA's Formal Feedback About SurVeil DCB

Wed, 29 Mar 2023 12:44:12 Surmodics' (SRDX) receipt of the FDA's positive formal feedback regarding its PMA application for the SurVeil DCB looks promising.... Read Full Article

Here's Why You Should Retain Avantor (AVTR) Stock for Now

Tue, 28 Mar 2023 15:40:03 Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.... Read Full Article

NextGen's (NXGN) New Cloud-Based Solution to Improve Workflow

Tue, 28 Mar 2023 15:21:03 NextGen's (NXGN) latest product is expected to simplify connectivity for healthcare providers, thereby solving clinical data exchange challenges.... Read Full Article

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Tue, 28 Mar 2023 15:12:03 Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.... Read Full Article

Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down

Tue, 28 Mar 2023 15:11:03 The U.S. Healthcare segment of Walgreens Boots (WBA) grows on key contract wins, continued partnership growth and a strong focus on execution during fiscal Q2.... Read Full Article

Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know

Mon, 27 Mar 2023 21:45:09 In the latest trading session, Hologic (HOLX) closed at $79.61, marking a +0.52% move from the previous day.... Read Full Article

Quest Diagnostics (DGX) Introduces New Post-COVID-19 Panels

Mon, 27 Mar 2023 15:28:03 Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers... Read Full Article

Here's Why You Should Retain Inogen (INGN) Stock for Now

Mon, 27 Mar 2023 14:22:02 Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.... Read Full Article

Catalent (CTLT) Inks Deal for Nasal Spray for Opioid Overdoses

Fri, 24 Mar 2023 15:16:03 Catalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible.... Read Full Article

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Fri, 24 Mar 2023 13:00:01 Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.... Read Full Article

Medtronic (MDT) to Enhance AI Innovation With New Platform

Thu, 23 Mar 2023 16:48:04 Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.... Read Full Article

3 Reasons to Retain QuidelOrtho (QDEL) Stock in Your Portfolio

Thu, 23 Mar 2023 16:19:04 Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.... Read Full Article

HOLX vs. EW: Which Stock Is the Better Value Option?

Thu, 23 Mar 2023 15:40:03 HOLX vs. EW: Which Stock Is the Better Value Option?... Read Full Article
<